# Ensysce Biosciences, Inc.: Form 8-K/A, filed Oct 16, 2026

- Company: [Ensysce Biosciences, Inc.](/companies/ensc.md) (CIK 1716947)
- Form: 8-K/A
- Filed: 2026-10-16
- Accepted by EDGAR: Oct 15, 2026, 21:56 ET
- Period: 2026-08-05
- Accession: 0001493152-26-047317
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1716947/000149315226047317/form8-ka.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1716947/000149315226047317/

## Items reported

- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1716947/000149315226047317/form8-ka.htm

Filed Oct 16, 2026.
Source: SEC EDGAR, the filing index for accession 0001493152-26-047317. Last ingested by Listed: Nov 4, 2026, 12:47 ET. No prices; not investment advice.